Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Momordica charantia fruit is the edible fruit of a climbing vine native to Asia and other tropical regions. Commonly known as bitter melon or karela among many other names worldwide[3][8], it has been used in traditional medicine for centuries. The primary bioactive compounds include phenolic compounds (such as flavonoids and triterpenoids), insulin-like peptides (notably polypeptide-p), and charantin[8]. These constituents are believed to contribute to its hypoglycemic effects by acting similarly to insulin and reducing blood sugar levels[1][4][5]. Bitter melon has also demonstrated antioxidant properties and potential anti-inflammatory activity. Other suggested uses include management of dyslipidemia (abnormal blood fat levels), obesity/weight loss support[8], non-alcoholic fatty liver disease prevention[8], cancer prevention (based on preclinical data)[5], antimicrobial effects[8], fever reduction[5][8], gastrointestinal upset relief[3][8], skin conditions such as psoriasis or burns treatment[3][8], fertility enhancement in folk medicine,[5] and pain relief during menstruation.[3] However clinical evidence supporting most uses is limited; the strongest data exist for its modest glucose-lowering effect in type 2 diabetes—though results are inconsistent across studies and not sufficient for routine therapeutic recommendation without medical supervision.[4] Momordica charantia fruit is available fresh or dried for culinary use or processed into extracts sold over-the-counter as dietary supplements.[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on momordica charantia fruit.